BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 11287617)

  • 1. Vav-Rac1-mediated activation of the c-Jun N-terminal kinase/c-Jun/AP-1 pathway plays a major role in stimulation of the distal NFAT site in the interleukin-2 gene promoter.
    Kaminuma O; Deckert M; Elly C; Liu YC; Altman A
    Mol Cell Biol; 2001 May; 21(9):3126-36. PubMed ID: 11287617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pleiotropic defects in TCR signaling in a Vav-1-null Jurkat T-cell line.
    Cao Y; Janssen EM; Duncan AW; Altman A; Billadeau DD; Abraham RT
    EMBO J; 2002 Sep; 21(18):4809-19. PubMed ID: 12234921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vav-induced activation of the human IFN-gamma gene promoter is mediated by upregulation of AP-1 activity.
    Kaminuma O; Elly C; Tanaka Y; Mori A; Liu YC; Altman A; Miyatake S
    FEBS Lett; 2002 Mar; 514(2-3):153-8. PubMed ID: 11943142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyrosine phosphorylation of Vav stimulates IL-6 production in mast cells by a Rac/c-Jun N-terminal kinase-dependent pathway.
    Song JS; Haleem-Smith H; Arudchandran R; Gomez J; Scott PM; Mill JF; Tan TH; Rivera J
    J Immunol; 1999 Jul; 163(2):802-10. PubMed ID: 10395673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Nck-Pak1 signaling module is required for T-cell receptor-mediated activation of NFAT, but not of JNK.
    Yablonski D; Kane LP; Qian D; Weiss A
    EMBO J; 1998 Oct; 17(19):5647-57. PubMed ID: 9755165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vav modulation of the Ras/MEK/ERK signaling pathway plays a role in NFAT activation and CD69 up-regulation.
    Villalba M; Hernandez J; Deckert M; Tanaka Y; Altman A
    Eur J Immunol; 2000 Jun; 30(6):1587-96. PubMed ID: 10898494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vav transformation requires activation of multiple GTPases and regulation of gene expression.
    Palmby TR; Abe K; Karnoub AE; Der CJ
    Mol Cancer Res; 2004 Dec; 2(12):702-11. PubMed ID: 15634759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of a role for Jun kinase and AP-1 in Fas-induced apoptosis.
    Lenczowski JM; Dominguez L; Eder AM; King LB; Zacharchuk CM; Ashwell JD
    Mol Cell Biol; 1997 Jan; 17(1):170-81. PubMed ID: 8972197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tyrosine phosphorylation of adaptor protein 3BP2 induces T cell receptor-mediated activation of transcription factor.
    Qu X; Kawauchi-Kamata K; Miah SM; Hatani T; Yamamura H; Sada K
    Biochemistry; 2005 Mar; 44(10):3891-8. PubMed ID: 15751964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tpl-2 induces IL-2 expression in T-cell lines by triggering multiple signaling pathways that activate NFAT and NF-kappaB.
    Tsatsanis C; Patriotis C; Tsichlis PN
    Oncogene; 1998 Nov; 17(20):2609-18. PubMed ID: 9840924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tyrosine phosphorylation of the vav proto-oncogene product links FcepsilonRI to the Rac1-JNK pathway.
    Teramoto H; Salem P; Robbins KC; Bustelo XR; Gutkind JS
    J Biol Chem; 1997 Apr; 272(16):10751-5. PubMed ID: 9099726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD43-mediated signals induce DNA binding activity of AP-1, NF-AT, and NFkappa B transcription factors in human T lymphocytes.
    Santana MA; Pedraza-Alva G; Olivares-Zavaleta N; Madrid-Marina V; Horejsi V; Burakoff SJ; Rosenstein Y
    J Biol Chem; 2000 Oct; 275(40):31460-8. PubMed ID: 10908570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A functional T-cell receptor signaling pathway is required for p95vav activity.
    Wu J; Katzav S; Weiss A
    Mol Cell Biol; 1995 Aug; 15(8):4337-46. PubMed ID: 7623828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RhoG regulates gene expression and the actin cytoskeleton in lymphocytes.
    Vigorito E; Billadeu DD; Savoy D; McAdam S; Doody G; Fort P; Turner M
    Oncogene; 2003 Jan; 22(3):330-42. PubMed ID: 12545154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. hSiah2 is a new Vav binding protein which inhibits Vav-mediated signaling pathways.
    Germani A; Romero F; Houlard M; Camonis J; Gisselbrecht S; Fischer S; Varin-Blank N
    Mol Cell Biol; 1999 May; 19(5):3798-807. PubMed ID: 10207103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of interleukin-2 transcription by inducible stable expression of dominant negative and dominant active mitogen-activated protein kinase kinase kinase in jurkat T cells. Evidence for the importance of Ras in a pathway that is controlled by dual receptor stimulation.
    Faris M; Kokot N; Lee L; Nel AE
    J Biol Chem; 1996 Nov; 271(44):27366-73. PubMed ID: 8910314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c-Jun N-terminal kinase (JNK) positively regulates NFATc2 transactivation through phosphorylation within the N-terminal regulatory domain.
    Ortega-Pérez I; Cano E; Were F; Villar M; Vázquez J; Redondo JM
    J Biol Chem; 2005 May; 280(21):20867-78. PubMed ID: 15743762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vav synergizes with protein kinase C theta to mediate IL-4 gene expression in response to CD28 costimulation in T cells.
    Hehner SP; Li-Weber M; Giaisi M; Dröge W; Krammer PH; Schmitz ML
    J Immunol; 2000 Apr; 164(7):3829-36. PubMed ID: 10725744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD28 co-stimulation restores T cell responsiveness in NOD mice by overcoming deficiencies in Rac-1/p38 mitogen-activated protein kinase signaling and IL-2 and IL-4 gene transcription.
    Zhang J; Salojin KV; Delovitch TL
    Int Immunol; 2001 Mar; 13(3):377-84. PubMed ID: 11222507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vav cooperates with CD28 to induce NF-kappaB activation via a pathway involving Rac-1 and mitogen-activated kinase kinase 1.
    Marinari B; Costanzo A; Viola A; Michel F; Mangino G; Acuto O; Levrero M; Piccolella E; Tuosto L
    Eur J Immunol; 2002 Feb; 32(2):447-56. PubMed ID: 11813163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.